Business · 10/03/2010Updated: 10/17/2026 · 1 min read

FDA to Hold Public Hearing on Expanded Access to Hepatitis C Treatment for Patients in Need

The FDA is seeking public input on expanded access programs for direct-acting antiviral agents to treat chronic hepatitis C in patients with unmet medical need, with a focus on identifying those at greatest risk of disease progression and lowest response rates.